書籍詳細

1. 貧血の系統診断法

P.25 掲載の参考文献

• 1) Wintrobe, M. M., Lee, G. R., Boggs, D. R., Bithell, T. C., Athens, J. W., Foester, J:Clinical Hematology 7th Ed., Lea & Febiger, Philadelphia, 1974.

• 2) Williams, W. J., Beutler, E., Erslev. A. J. and Rundles, R. W.:Hematology 2nd Ed., McGraw-Hill, N.Y., 1977.

• 3) 高久史麿:貧血の成因とその分類, 内科31:604~614, 1973.

• 4) Begemann, H., Rastetter, I. und Kaboth, W.:Klinische Hamatologie 2Auflage, Georg Thieme, Stuttgart, 1975.

• 5) 高久史麿:赤血球の減少と増加, 診断と治療, 64:185〜189, 1976.

• 6) 中尾喜久編:内科シリーズNo. 14貧血のすべて, 南江堂, 東京, 1975.

• 7) 宮崎保:日本医師会医学講座昭和46年度. 鉄代謝からみた貧血の診断と治療 (鉄欠乏性貧血を中心として) 金原出版. 東京, 1971.

• 8) 宮崎保, 倉根理一, 柏木茂夫:鉄代謝, 綜合臨牀20:1433〜1442, 1977.

• 9) 宮崎保:血液疾患, 貧血, 綜合臨牀, 26:増刊2140〜2145, 1977, 1977年 版, 検査計画法.

• 10) 宮崎保, 倉根理一, 若田朝子:鉄代謝異常による貧血, 治療60:1431〜1443, 1978.

• 11) 松本昇, 三輪史朗:貧血の診断の進め方, 治療, 60:1415〜1421, 1978.

• 12) Hillman, R.S. & Finch, C. A.:Red Cell Manual, 4th Ed., F. A. Davis Co., Philadelphia, 1974.

2. 貧血の病態生理

P.71 掲載の参考文献

• 1) Granik, S.:Iron metabolism. Bull. N. Y. Acad. Med., 30:81-105, (1954)

• 2) Beutler, E., Fainbanks, V. F. and Fahey, J. L.:Clinical disorders of iron metabolism. Grune and Stratton, N. Y. (1963)

• 3) 刈米重夫:鉄の回転. 最新医学, 21:1639〜1648, (1966)

• 4) Huff, R.L, Hennessy, T.G・, Austin, R.E., Garcia, J.F., Roberts, B.M. and Lawrence, J.H.:Plusma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders. J. Clin. Invest., 29:1041-1052, (1950)

• 5) Huff, R. L., Elmlinger, P. L., Garcia, J.H., Oda, J.M., Cockrell, M.C. and Lawrence, J. H.:Ferrokinetics in normal persons and in patients having various erythropoietic disorders. J. Clin. Invest., 30:1512-1526, (1951)

• 6) 刈米重夫:フェロキネティクス. 綜合臨床, 18:1609〜1616, (1969)

• 7) Green, R., Chalton, R., Seftel, F., Adams, B., Finch, C. and Layrisse, M.:Body iron excretion in man. Amer. J. Med., 45:336-353, (1968)

• 8) Moore C. V., Bubach, R., Minnich, V. and Roberts, H. K.:Absorption of ferrous and ferric radioactive iron by human subjects and by dogs. J. Clin. Invest., 23:755-757, (1944)

• 9) Callender ST, Mallett, B. J. and Smith, M. D.:Absorption of haemoglobin iron. Brit. J. Haemat., 3:186-192, (1957)
  pubmed

• 10) Turnbull, A., Cleton, F. and Finch, C. A.:Iron absorption of hemoglobin iron. J. Clin. Invest., 41:1897-1907, (1962)
  pubmed

• 11) Huebers, H., Huebers, E and Rummel, W.:Mechanism of iron absorption:Iron binding proteins and dependence of iron absorption on an elutable factor. Iron metabolism and its disorders. Ed. Kief, Excepta Medica, p. 13-24, (1975)

• 12) 刈米重夫, 富田重良, 他:鉄の吸収. 最新医学, 20:3114〜3122, (1965)

• 13) Granick, S.:Protein apofferritin and ferritin in iron feeding and absorption. Science, 103:107, (1946)

• 14) Heizlich, H. C., Gabbe, K. H., Oppitz, K H. et al:Absorption of In organic and food iron in children with heterozygous and homozyglus β-thalassemia:Z. Kinderheilkunde, 115:1-22, (1973)

• 15) Bender-Gotze, Heinlich, H. C., Gabbe, E.E. et al:Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Z. Kinderheilkunde, 118:283-301, (1975)

• 16) Wheby, M. S. and Crosby, W. H.:The gastrointestinal tract and iron absoption. Blood, 22:416-428, (1963)

• 17) Fawwaz, R. A., Winchell, H. S., Polycove, M. and Sargent, T.:Hepatic iron deposition in humans. I. First pass hepatic deposition of intestinally absobed iron in patients with low plasma latent iron binding capacity. Blood, 30:417-424, (1967)

• 18) 刈米重夫, 藤井正博:消化管内出血の定量. 日消会誌, 64. 9〜11, (1967)

• 19) 白川 彰:鉄欠乏性貧血の赤血球寿命に関する研究 (第3編), 鉄欠乏性貧 血患者の出血量ならびにその赤血球寿命との関係について. 内科宝函, 14: 65〜74, (1967)

• 20) 菊地成夫:糞便中の血液反応に関する実験的研究. 東北医誌, 30:643〜650, (1942)

• 21) Heinlich, H. C.:Clinical aspects of iron absorption and turnover. Iron metabolism and its disorders. Ed. Kief. Excepta Medica p. 34-61, (1975)

• 22) Heilmyer, L.:Die Hamochromatose:Klinik, Eisenstoffwechsel and Pathogenese. Acta Haemat., 11:137-151, (1954)

• 23) Herbut, P. A. and Tamaki, H. T.:Chirrhosis of the liver and diabate as related to hemochromatosis. Am. J. Clin. Path., 16:640-650, (1946)

• 24) Higginson, J., Gerritsen, T. and Walker, A. R. P.:Siderosis in the Bantu of Southern Africa. Am. J. Path., 29:779-815, (1953)

• 25) Hughes, J. T. and Truelove, L. H.:Transfusional haemosiderosis simulating hemochromatosis. J. Clin. Path., 11:128-132, (1958)
  pubmed

• 26) Hellier, F. F.:The nature and causation of skin pigmentation in hemochromatosis. Brit. J. Dermat., 47:1-12, (1935)

• 27) Mac Donald, R. A. and Mallory, G. K.:Hemochromatosis and hemosiderosis. Study of 211 antopsied cases. Arch. Int. Med., 105:686-700, (1966)

• 28) Wintrobe, M. M. and Beebe, R. T.:Idiopathic hypochromic anemia. Medicine, 12:187-243, (1933)

• 29) Heilmyer, L.:Die Behandlung eisen empfindlicher Antimien mit askorbin sauren Eisen, Zuglich ein Beitrag Zum Mechanismus der Eisenwirkung und Zur Frage der Eisenmangelkrankheit. Deutsch. Arch. Klin. Med., 179:216-231, (1936)

• 30) Badenoch, J., Evans, J. R. and Richard, W. C. D.:The stomach in hypochromic anemia. Brit J. Heam., 3:175-185, (1957)

• 31) 刈米重夫:脾シンチグラフィー. シンチグラフィーの基礎と臨床, 金原出版, 東京 (1970)

• 32) 刈米重夫:鉄および鉄結合能. 日本臨床, 1976年秋季増刊, 血液, 尿化学検査, p. 2007〜2015, (1976)

• 33) Lipschitz, D. A., Cook, J. D. and Finch, C. A.:A clinical evaluation of serum ferritin as an index of iron stores. New Engl. J. Med., 290:1213-1216, (1974)
  pubmed

• 34) Heilmyer, L, Keiderling, W., Bilger, R. und Bernaner, H.:Ueber chronische refraktare anamien mit sideroblastischen Knochen Mark. (Anemia refractoria sideroblastica) . Folia haemat. Bd. 2., p. 49-60, Neue Folge, Frankfurt am Main. (1958)

• 35) Singh, A. K., Shinton, N. K. and William, J. D. F.:Ferrokinetics abnormalities and their significance in patients with sideroblastic anemia. Brit. J. Heamat., 18:67-77, (1970)

• 36) Hillman, R. S. and Henderson, P. A.:Control of marrow production by the level of iron supply. J. Clin. Invest., 48:454-460, (1969)
  pubmed

• 37) Hegsted, D. M., Finch, C. A. and Kinney, T. D.:The influence of dient on iron absorption. II. The interrelation of iron and phosphorus. J. Exp. Med., 90:147-156, (1949)

• 38) Conrad, M. E. and Schade, S. G.:Ascorbic acid chelates in iron absorption:A role for hydrochloric acid and bile. Gastroenterology, 55:35-45, (1968)
  pubmed

• 39) Brise, H. and Hallberg, L.:Iron absorption studies. II. Acta Med. Scand., 171 (suppl.):376 (1962)

• 40) 脇坂行一, 内野治人ほか:筋肉内注射用鉄剤 Jectofer (iron-sorbitol citric acid complex) に関する臨床実験. 内科宝函, 9:307〜319, (1961)

• 41) 脇坂行一, 刈米重夫ほか:鉄欠乏性貧血の鉄代謝異常とその治療. 日本臨床, 19:307〜319, (1961)
  Medical*Online

• 42) 脇坂行一, 刈米重夫:コロイド鉄および熱処理赤血球を用いた網内系機能に 関する研究. 日本網内系会誌, 4:32〜46, (1962)

• 43) Hines, J. D. and Grasso, J. A.:The sideroblastic anemias. Semminars Haemat., 7:86-106, (1970)

• 44) Heilmyer, V. L., Emmeich, J., Henneman, H. H., Keiderling, W., Lee, M., Blinger, R. und Schubothe, H,:Uber eine chronische hypochrome Anamie bei zwei Geschwistern auf der Grundlarge einer Eisenverwertung Storung. (Anemia hypochromia sideroachrestica hereditaria) . Folia Haemat. 2:61-75. (1958)

• 45) Verloop, M. C., Ploem, W. and Leumis, J.:Hereditary iron-loading anemia. Iron metabolism. Ed. Gross. F. p. 376-387, Sprillger Verlag, Berlin. (1964)

• 46) Barry, W. E. and Day, H. J.:Refractory sideroblastic anemia. Ann. Intern. Med., 61:1029-1044, (1964)
  pubmed

• 47) Mac Gibbon, B. H. and Mollin, D. L.:Sideroblastic anemia in man. Observations on seventy cases. Brit. J. Haemat., 11:59-69. (1965)

• 48) Dacie, J. V., Smith, M. D., White, J. C. and Mollin, D. L.:Refractory normoblastic anemia;A clinical and hematological study of seven cases. Brit. J. Haem., 5:56-82, (1959)

• 49) Petz, L. D., Googman. J. R, Hall, S. G. and Fink, D. J.:Refractory normoblastic anemia;Clinical and electron microscopic observations. Amer. J. Clin. Path., 45:581-599, (1966)

• 50) Harris, J. W., Whittington, R. N., Weisman, R. Jr. and Horrigan, D.L.:Pyridoxine-responsive anemia in the human adult. Proc. Soc. Exp. Biol. Med., 91:427-432, (1956)

• 51) Raab, S. O., Haut, A., Cartwright, G. E. and Wintrobe, M. M.:Pyri-doxine-responsive anemia. Blood, 18:285-302, (1961)

• 52) Heilmyer, V. L. and Clotten, R.:Die Storungen der Porphyrin Synthese bei den sideroachrestischen Anamien. Schw. Med. Wschr., 34:934-938, (1960)

• 53) Vegler, W. R. and Mingioli, E. S.:Improvement in heme synthetase activity in pyridoxine responcive anemia by reduction in iron stores. Blood, 30:866-867, (1967)

• 54) Gardner, F. H. and Nathan, D. G.:Hypochromic anemia and hemochromatosis;Response to combined testosterone, pyridoxine, and liver extract therapy. Amer. J. Med. Sci., 243:447-457, (1962)
  pubmed

• 55) Vavra, J. D. and Poff, S. A.:Heme and porphyrin synthesis in sideroblastic anemia. J. Lab. Clin. Med., 69:904-918, (1967)
  pubmed

• 56) 高久史麿, 中尾喜久:鉄芽球性貧血-とくに赤芽球におけるヘム合成異常を 中心として. 医学のあゆみ, 77:373~378, (1971)

• 57) Besis, M. C. and Jensen, W. N.:Sideroblastic anemia, mitochondria and erythroblastic iron. Brit. J. Heamat., 11:49-51, (1965)

• 58) Verloop, M. C., Bierenga, M. and Diezeraad-Njoo, A.:Primary or essential sideroblastic anaemias. Acta Haemat., 27:129-145, (1962)
  pubmed

• 59) Wultuck, G., Lauzerotti, A. K. and Schrier, S. L.:Marrow defect in idiopathic ineffective erythropoiesis. Ann. Intern. Med., 68:1005-1012, (1968)

• 60) Gehrman, G.:Pyridoxin-responsive anaemias. Brit. J. Haem. II, 86-91, (1965)

• 61) Dameshek, W.:Some speculations on the myeloproliferative syndromes. Blood, 6:372-375, (1951)
  pubmed

• 62) Dameshek, W.:The Di Guglielmo syndrome. Blood, 13:192-194, (1958)
  pubmed

• 63) Hayhoe, F. G. J. and Quaglino, D.:Refractory sideroblastic anemia and evrythremic myelosis Brit. J Haemat., 6:381-387, (1960)

• 64) Gatovsky, D., Shaw, M. T., Hoffsrand A. V. and Dacie, J. V.:Sideroblast anemia and its association with leukemia and myelomatosis ; A report of five cases, Brit. J. Haemat., 20:385-33 (1971)

• 65) Thurm, R. H., Casey, M. J. and Emerson C. P.:Chronic Di Guglielmo syndrome. Amer. J. Med. Sci., 253:399-405, (1967)
  pubmed

• 66) Eastman, P. M., Schwartz, R. and Schrier, S. L.:Distinctions between idiopathic ineffective erythropoieses and di Guglielmo's disease:Clinical and biochemical differences. Blood, 40:487-499, (1972)
  pubmed

P.107 掲載の参考文献

• 1) Chanarin, I.:The megaloblastic anaemias, Blackwell Scientific Publ., Oxford and Edinburgh, 1969.

• 2) 福井三郎:ビタミンB12の生化学, 血液と脈管, 2:1465〜1469, 1971.

• 3) Beck, W.S.:Vitamin B 12 deficiency, Hematology (Williams, W.J., et al ed.), McGraw-Hill, New York, 257-278, 1972.

• 4) 右京成夫:尿中メチルマロン酸排泄とビタミン B12 代謝, ビタミン B12 (内野治人編集) 科学評論社, 東京, 266〜295, 1978.

• 5) 内野治人:巨赤芽球性貧血, 病態血液学 (脇坂行一監修, 内野治人, 刈米重夫, 編集), 南江堂, 東京, 170〜185, 1977.

• 6) Ellenbogen, L.:Absorption and transport of cobalamin, Cobalamin (Babior, B.M. ed,) Wiley-Interscience Publ. New York, 215-286, 1975.

• 7) Hall, C. A.:Transport of vitamin B 12 in man, Brit. J. Haematol., 16:429-435, 1969.

• 8) 阿部師:悪性貧血と胃の自己免疫, ビタミンB12 (内野治人編集) 科学評論社, 東京, 81〜98, 1978.

• 9) 藤村欣吾, 内野治人:悪性貧血の成因に関する自己免疫的考察, ビタミン B12 (内野治人編集) 科学評論社, 東京, 99〜121, 1978.

• 10) 森下玲児, 日比野敏行, 内野治人:Whole. body counterのビタミンB12吸収試験ならびにB12代謝への応用, ビタミン B12 (内野治人編集) 科学評論社, 東京, 53〜80, 1978.

• 11) Cooper, B. A.:Megaloblastic anaemia and disorders affecting utilization of vitamin B12 and folate in childhood, Clinics in Haematology, 5:631-659, 1976.
  pubmed

• 12) 内野治人, 藤村欣吾, 寺谷美枝子:ビタミンB12欠乏症, 血液と脈管, 2: 1483〜1488, 1971.

• 13) 岩井和夫:葉酸の基礎, 葉酸 (内野治人, 外林秀紀編集) 科学評論社, 東京, 7〜84, 1977.

• 14) Hoffbrand, A. V.:Syntesis and breakdown of natural folates (folate polyglutamates), Progress in Hematology, 9:85-105, 1975.

• 15) 外林秀紀:巨赤芽球性貧血, 病態血液学 (脇坂行一監修, 内野治人, 刈米重夫 編集), 南江堂, 東京, 170〜185, 1977.

• 16) Herbert, V., and Das, K.C.:The role of vitamin B 12 and folic acid in hemato-and other cell-poiesis, Vitamins and Hormones, 34:1-30, 1976.
  pubmed

• 17) Das, K. C., and Herbert, V.:Vitamin B 12-folate interrelations, Clinics in Haematology, 5:697-725, 1976.
  pubmed

• 18) Metz, J., Kelly, A., Swett, V. C., Waxman, S., and Herbert, V.:Deranged DNA synthesis by bone marrow from vitamin B 12 deficient humans. Brit. J. Haemat., 14:575-592, 1968.
  pubmed

• 19) Waxman, S., Cortino, J. J.. and Herbert, V.:Drugs, toxins and dietary amino acids affecting vitamin B 12 or folic acid absorption or utilization. Am. J. Med., 48:599-608, 1970.

• 20) Killman, S. A.:Effect of deoxyuridine on incorporation of tritiated thymidine. Difference between normoblasts and megaloblasts. Acta Med. Scand., 175:483-488, 1964.

• 21) Hoffbrand, A. V.:Vitamin-B 12 and folate metabolism:the megaloblastic anaemia and related disorders. Blood and its disorders (Hardisty, R.M. and Weatherall, D. J. ed.) Blackwell Scientific Publ., Oxford, 392-472a, 1974.

• 22) Herbert, V.:Folic acid deficiency in man. Vitamins & Hormones, 26:525-535, 1968.
  pubmed

• 23) 外林秀紀:葉酸利用障害, 葉酸 (内野治人, 外林秀紀編集) 科学評論社, 東京, 362〜399, 1977.

• 24) 外林秀紀:ビタミン B12 と葉酸代謝, ビタミン B12 (内野治人編集) 科学評論社, 東京, 208〜232, 1978.

• 25) Beck, W. S,:Megaloblastic anemia unresponsive to vitamin B 12 or folic acid. Hematology (Williams, W. J. et al. ed.), McGraw-Hill, New York, 297-304, 1972.

P.148 掲載の参考文献

• 1) Weiss, L:The blood cell and hematopoietic tissues, 545. Mc-Graw-Hill. Inc. New York. 1977.

• 2) 今井 環:日血全書, 第1巻:757. 丸善, 東京, 1961.

• 3) Rappaport, H:Milz/Spleen, 24 Springer-Verlag, 1970.

• 4) Schmid-Schoenbein, H:ibid. 67.

• 5) Mondorf. W, et al:ibid. 162.

• 6) 松本武四郎:日病会誌57:37, 1968.

• 7) Ford, W. L. and Nieuwenhus, P.:Schweiz. med. Wschr. 104:1348 1974.

• 8) Weiss, L:Blood 43:665, 1974.
  pubmed

• 9) Koyama, S. et al:Mie Med. J. 14:143, 1964.
  pubmed

• 10) Schnitzer, B, et al:Blood 41:207, 1973.
  pubmed

• 11) Kniseley, M. H,:Anat. Rec. 65:23, 1936.

• 12) 中田勝次:血液学討議会報告, 第7輯, 36, 1954.

• 13) Harris, J. M, et al:Brit. J. Haematol. 4:97, 1958.

• 14) Takahashi, Y.:Act. Haematol. Jap. 30:83, 1967.

• 15) Takahashi, Y. et al:Proceedings of the first world congress of nuclear medicine. 97-World Federation of Nuclear Medicine & Biology, 1974.

• 16) Jandle, J. H, and Aster, R. H.:Amer. J. Med. Sci. 253:383, 1967.

• 17) Kariyone, S. et al.:Act Haematol. Jap. 36:138, 1973.

• 18) Crosby, W. H.:Blood. 14:399, 1959.
  pubmed

• 19) Jandle, ]. H,:J. Clin Invest. 39:1145, 1960.

• 20) Jandle, J. H,:J. Clin Invest 41:1514, 1962.

• 21) Wagner, H. N.:Arch Intern. Med 110:128, 1962.

• 22) Doan, C. A. and Writ, C. S.:Blood 1:10, 1956.

• 23) Aster, R. H.:J. Clin. Invest., 45:645, 1966.
  pubmed

• 24) Najean, Y. et al:Brit. J. Haemat. 13:409, 1967.
  pubmed

• 25) Firkin, B. G. et al:Blood, 33:240, 1969.
  pubmed

• 26) Toghil, P. J. and Green. S, J:Clin. Path. 25:570, 1971.

• 27) Blendis, L. M. et al,:Europ. J. Clin Invest 1:54, 1970.
  pubmed

• 28) Bishop, C. R.:J. Clin. Invest. 50:1678, 1971.
  pubmed

• 29) Uchida, T., and Kariyone, S.:J. Lab. Clin. Med. 82:9, 1973.
  pubmed

• 30) Sprent. J.:in the Lymphocyte Structure and Function. Part 1, ed. by Marchalonis J. J. p 43. Marcel. Dekken. Inc. N. Y. 1977.

• 31) 中田勝次:厚生省特定疾患, 特発性門脈圧亢進症調査研究班. 昭和52年度業 績集. 54, 1978.

• 32) 高橋 豊:ibid., 106, 1978.

• 33) 高橋 豊:厚生省特定疾患, 特発性門脈圧亢進症調査研究班, 昭和51年度業績集, a) 111〜114, b) 140〜149, 1977.

• 34) Scot, J. L, Davidson, J. G, et al:proc XIII Ann Meeting. Am Soc. Hematol. Puerto Rico. 6, Dec. 1970, p. 42.

• 35) Rubenstroth-Bauer. G.:Seminars in Hematol. 2:229, 1965.

• 36) Noyes. W. D. et al:Brit. J. Haematol 6:43, 1960.

• 37) Blaustein, A. U. and Diggs, L W.:in ths Spleen. 45, ED. Blaustein, A. McGraw-Hill, N. Y. 1963.

• 38) Takahashi, Y. and Kariyone. S,:in Proc. XVI Intern. Cong. Hematol. 544-547. Excerpta Medica. Amsterdam. 1977.

• 39) Doan, C. A.:Bull, N. Y. Acad. Med. 25:625, 1949.
  pubmed

• 40) Dameshek, W.:Bull, N. Y. Acad, Med 31:113, 1955.
  pubmed

• 41) Amorosi, E. L:Seminars, Haematol. 2:229, 1965.

• 42) 高橋 豊:日血会誌. 30:119, 1967.

• 43) Haaga, J. and Reich, N. E:Computed Tomography of Abdominal Abnormalities. C. V. Mosby Co. Saint Louis 1978.

• 44) Kupic, E. A. et al:Invest. Radiol. 2:70. 1967.
  pubmed

• 45) International Committee for Standardization in Hematology:Blood 38:378, 1971.

• 46) 宇山親雄, 他:医用電子と生体工学15:16, 1977.

• 47) 高橋 豊:臨床病理 21:329, 1973.
  Medical*Online

• 48) Weed, R. I.:Arch. Int. Med 135:1316, 1975.

• 49) Molnar, L. and Rappaport, H.:Blood 39:81, 1972.

• 50) Cooper, R. A. et al.:N. Eng. J. Med. 290:1279, 1974.

• 51) 三輪史朗:血液疾患最近の進歩130, 金原出版, 東京, 1978.

• 52) 八幡義人:ibid, p. 119.

• 53) 柴田 昭:ibid, p. 235.

• 54) 福田芳郎:ibid, p. 345.

• 55) Nathan, D. G. et al:N. Eng. J. Med. 278:73, 1968.

• 56) Mentzer. W. C. et al.:J. Clin. Invest-50:688, 1971.
  pubmed

• 57) Matsumoto, N. et al:Acta. Haematol. Jap. 36:46, 1973.

• 58) Rifkind, R. A.:Blood 26:433, 1965.
  pubmed

• 59) Wennberg, E, and Weiss, L.:Blood 31:778, 1968.

• 60) Slater. L. M. and Weed, R. I.:Blood, 31:766, 1968.
  pubmed

• 61) Jensen. W. N. and Lessin, L. S.:Seminars Haematol, 7:409, 1970.

• 62) Allgood, J. W. and Chaplin, H. Jr.:Amer. J. Med. 43:254, 1967.
  pubmed

• 63) Dacie. J. V.:Arch. Int. Med. 135:1293, 1975.

• 64) Lo Buglio, A. F. et al:Science 158:1582, 1967.
  pubmed

• 65) Huber. H.:Science 162:1282, 1968.

• 66) Rosse, W. F. and Lauf. F. K.:Seminars. Haematol. 7:323, 1970.

• 67) Brabec, V.:Blood 34:414, 1969.
  pubmed

• 68) Gomperts, E. D. et al:Brit. J. Haematol 25:421, 1973.

• 69) Cooper, R. A,:J. Clin Invest. 51:16, 1972.
  pubmed

• 70) Goldberg, A. et al:Lancet 1:109, 1966.
  pubmed

• 71) 島峰徹郎:日血全書. 第4巻618, 丸善, 東京, 1965.

• 72) Rappaport, H. and Crosby, W. H.:Am. J. Path. 33:429, 1957.

• 73) 脇坂行一:現代内科学大系, 血液造血器疾患, IIb, 203, 中山書店. 東京, 1962.

• 74) 上田英雄, 他:内科, 21:340, 1968.

• 75) 杉浦光雄:Medicina 14:1838, 1977.

• 76) 山本真博:肝硬変のすべて, p. 149, 南江堂, 東京・京都, 1975.

• 77) 志方俊夫, 他:肝臓17:417, 1976.

• 78) 高橋 豊:綜合臨牀 27:592, 1978.

• 79) Hess, C. E. et al:Blood, 47:629, 1976.
  pubmed

• 80) Kawakita, Y, et al:Jap. J. Clin. Hematol. 14:1247, 1973.

• 81) Crosby, W. H.:New Eng. J. Med. 286:1252, 1972.
  pubmed

• 82) Ward, H. P. and Block, M. H.:Medicine 50:357, 1971.
  pubmed

• 83) Tavassoli, M, and Weiss, L,:Blood 42:267. 1973.

• 84) Milner, G. R. et al:Brit. J. Haematol. 25:467, 1971.

• 85) Katayama, I. and Finkel, H. E.:Amer J. Med. 57:115. 1974.
  pubmed

• 86) Burk, J. S. et al:Cancer. 33:1399, 1974.

• 87) Gomer, M M. R, et al:Surg. Gynecol. Obstet. 129:129, 1969.

• 88) Erickson, W. D. et al:Amer, J. Dis, Child. 116:1, 1968.
  pubmed

• 89) Wintrobe, M. M.:Clinical Hematology. Chapt. 21, 27, 45, 56. Lea & Febiger, Philadelphia, 1974,

• 90) Crosby W. H.:in Hematology ED. Williams, WJ, Beutler, E, Erslev, AJ. and Rundles. R. W. p. 74, 611, McGraw-Hill. N. Y. 1977.

• 91) 脇坂行一, 内野治人, 刈米重夫:病態血液学 p.9, 71, 83, 191, 287, 308, 南江堂, 東京, 1977.

• 92) McMillan. R:New Eng. J. Med, 291:812, 1974.
  pubmed

• 93) Dixon, R. et al:New Engl. J. Med 292:230, 1975.
  pubmed

P.205 掲載の参考文献

• 1) 青木国雄, 大谷元彦:再生不良性貧血患者の全国実態調査 (第2報), 再生不良性貧血II:1〜8, 1974

• 2) 青木国雄, 大谷元彦:再生不良性貧血患者の全国実態調査 (第3報), 再生不良性貧血II:9〜28, 1974

• 3) 青木国雄, 清水弘之:再生不良性貧血の宿主要因, 再生不良性貧血III:1〜8, 1975

• 4) 服部絢一:日本の医学の1959. IV:168, 1959

• 5) 高久史麿, 武藤良知:Chloramphenicol と再生不良 性貧血に関する疫学的ならびに臨床血液学的検討. 再生不良性貧血V:79〜91, 1977

• 6) 市丸道人, 石丸虎之助:原爆放射線被曝と再生不良性貧血. 広島, 長崎の原爆被爆者の再生不良性貧血の発生率 (1950~1973). 再生不良性貧血IV:139〜145, 1976

• 7) 北畠隆, 他:放射線治療後の血液病発生状況の調査, 再生不良性貧血IV: 147〜156, 1976

• 8) 北畠隆, 他:本邦放射線技師における再生不良性貧血. 再生不良性貧血IV: 157〜160, 1976

• 9) 上田英雄, 他:最近経験せるゴムのり使用者の 再生不良性貧血症例について, 日本医事新報 No. 1849;3〜10, 1959

• 10) 上田英雄, 他:慢性ベンゾール中毒症の造血障害, とくにビニール加工作業 員の調査成績について, 内科5:871〜885, 1960

• 11) 島正吾, 他:再生不良性貧血の成因に関する 産業別疫学調査 (第二報). 再生不良性貧血III:19〜32, 1975

• 12) 青木国雄, 他:Chloramphenicol と再生不良性貧血の関連についての疫学的検討, 再生不良性貧血IV:33〜38, 1976

• 13) 長谷川彌人, 他:肝炎後再不貧の臨床統計的観察. 再生不良性貧血II:219〜226, 1974

• 14) Bottiger, L. E. ; Prelevalence and etiology of aplastic anemia in Sweden. A plastic Anemia, Univ. Tokyo Press. 1977, 171-180

• 15) 藤木典生, 他:再生不良性貧血の 臨床遺伝学的研究 (III) . 再生不良性貧血 V:45〜54, 1977

• 16) 瀬崎達雄:再生不良性貧血における血清 haptoglobin の遺伝型分類に関する研究, 再生不良性貧血V:67〜69, 1977

• 17) 高久史麿, 他:再生不良性貧血における造血幹細胞の動態. 再生不良性貧血 II:93〜96, 1974

• 18) 山田英雄, 他:再生不良性貧血の造血幹細胞障害に関する研究. 再生不良性貧血II:97〜107, 1974

• 19) 高久史麿, 他:再生不良性貧血における穎粒球ならびに赤血球系幹細胞に関する研究. 再生不良性貧血IV:1〜4, 1976

• 20) 永井清保, 他:再生不良性貧血患者白血球のCSF産生能とコロニー形成細 胞数. 再生不良性貧血III:51〜61, 1975

• 21) 田代浩二, 他:剖検統計による再生不良性貧血の病像の検討, 再生不良性貧血III:175〜181, 1975

• 22) 島峰徹郎, 他:再生不良性貧血骨髄の病理学的分類の検討, 再生不良性貧血 II:145〜150, 1974

• 23) 外村昌, 山田清美:再生不良 性貧血の 細胞遺伝学的研究. 再生不良性貧血 II:113〜114, 1974

• 24) 内野治人, 他:再生不良性貧血例における 骨髄細胞染色体分析に関する研究, 再生不良性貧血II:115〜120, 1974

• 25) Lewis, S. M.& Dacie, J. V.:The a plastic anemia-paroxysmal nocturnal haemoglobinuria syndrome. Brit. J. Haemat. 13:236-251, 1967

• 26) Gardner, F. H.:A plastic anemia Syndrome in paroxysmal nocturnal haemoglobinuria, Aplastic Anemia. Univ. Tokyo Press, 1977, 273-284

• 27) Gardner, F. H., & Blum, S. F.:A plastic anemia in paroxysmal nocturnal hemoglobinuria. Semin. Hemat. 4:250-256, 1967

• 28) 三輪史朗, 他:再生不良性貧血の赤血球 glutathione reductase に関する 研究 (第3報). 再生不良性貧血V:173〜179, 1977

• 29) Bloom, G. E. and Diamond, LK.:Prognostic value of fetal hemoglobin levels in aplastic anemia, New England J. Med. 278:304-312, 1968

• 30) 植田穣, 他:再生不良性貧血患者の未梢血HbF量, 再生不良性貧血III: 249〜252, 1975

• 31) Lie, F. P. et al.:The mortality of acquired a plastic anemia in children. Blood 40:153-162, 1972

• 32) 田中正夫, 他:再生不良性貧血における胎児性造血 (HbF) の推移, 再生不良性貧血IV:333〜339, 1976

• 33) 滝川清治, 他:再生不良性貧血患者好中球の趨化性について, 再生不良性貧血III:253〜254, 1975

• 34) 市丸道人, 他:再生不良性貧血と好中球アルカリフォスファターゼ活性, 再生不良性貧血V:181〜184, 1977

• 35) 田口信行, 他:小児期再不貧の免疫グロブリンと末梢好中球NBT試験, 再 生不良性貧血III:329334, 1974

• 36) 柴田昭, 他:再生不良性貧血患者における白血球NBTテスト. 再生不良性貧血IV:341〜343, 1976

• 37) 菊池昌弘, 他:再生不良性貧血剖検例のリンパ組織について. 再生不良性貧血IV:315〜322, 1976

• 38) 高久史麿, 他:再生不良性貧血における末梢血リンパ球subpopulation. 再生不良性貧血III:291〜294, 1975

• 39) 市丸道人, 木下研一郎:特発性再生不良性貧血リンパ球の免疫能について, 再生不良性貧血III:303〜306, 1975

• 40) 原田実根, 服部絢一:再生不良性貧血における細胞性免疫能, 再生不良性貧 血III:307〜312, 1975

• 41) 山田英雄, 他:再生不良性貧血の末梢血リンパ球 subpopulation に関する検討, 再生不良性貧血III:295〜298, 1975

• 42) 岩崎一郎, 他:再生不良性貧血のリンパ球, 再生不良性貧血III:299〜302, 1976

• 43) 青木国雄, 他:特定病院における最近5年間の再生不良性貧血患者の頻度分布と5年生存率, 再生不良性貧血II:29〜38, 1974

• 44) Vincent, P. C. and Gruchy, G. C.:Complications and treatment of acquired aplastic anemia. Brit. J. Haemat. 13:977, 1967

• 45) Camitta, B. M., et. al:Severe a plastic anemia:A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63-70, 1976

• 46) Lynch, R. E., et. al:Tre prognosis in aplastic anemia. Blood 45:517-528, 1975

• 47) Najean, Y., et al:A prospective analysis of 350 cases of aplastic anemia. A plastic Anemia. Univ. Tokyo Press, 1977, 181-184

• 48) 永井清保, 原宏:Chloramphenicol 投与により惹起された肝炎・再不貧症 候群, 再生不良性貧血II:233〜238, 1974

• 49) 柴田昭, 福田光之:Chloramphenicol -肝炎-再生不良性貧血症候群と考 えられる症例について, 再生不良性貧血II:239〜242, 1974

• 50) 山田英雄, 他:成人再生不良性貧血における血清免疫グロブリン値, 再生不良性貧血IV:277〜281, 1976

P.233 掲載の参考文献

• 1) 三輪史朗:溶血性貧血. In 新内科学大系, 第49巻, 血液・造血器疾患I, 中山書店, 1976:pp. 207〜244.

• 2) 松本昇:赤血球膜の異常. 膜 (MEMBRANE), 3(1):2〜12, 1978.

• 3) Jacob, H. S.:The abnormal red-cell membrane in hereditary spherocytosis:Evidence for the causal role of mutant microfilaments. Brit. J. Haemat., 23 (Suppl.):35-44, 1972.

• 4) Feig, S. A. & Guidotti, G.:Relative deficiency of Ca2+ dependent adenosine triphosphatase activity of red cell membranes in hereditary spherocytosis. Biochem. Biophys. Res. Comm., 58:487-494, 1974.
  pubmed

• 5) 小峰光博ほか:溶血性貧血患者の全国実態調査, 第二報, 遺伝性球状赤血球 症と免疫性溶血性貧血の臨床病態. 厚生省特定疾患溶血性貧血調査研究班昭 和50年度研究報告書 (班長三輪史朗), 1976, pp. 41〜55.

• 6) Miwa, S.:Congenital hemolytic anemias:A review of recent progress. Bull. Yamaguchi Med. School, 23:131-163, 1976.

• 7) Shohet, SB., Nathan, D. G., Livermore, B.M., Feig, S.A. & Jaffe, E.R.:Hereditary hemolytic anemia associated with abnormal lipid. II. Ion permeability and transport abnormalities. Blood, 42:1-8, 1973.
  pubmed

• 8) 三輪史朗:赤血球酵素異常による先天性溶血性貧血. 内科シリーズNo. 14 (中尾喜久編), 貧血のすべて, 南江堂, 1974, pp, 171〜187.

• 9) Stanbury, J. B., Wyngaarden, J. B. & Fredrickson, D. S. (eds.):The Metabolic Basis of Inherited Disease. 4th Ed., McGraw-Hill, New York, 1978, pp. 1396-1523.

• 10) Williams, W. J., Beutler, E., Erslev, A. J. & Rundles, R. W. (eds.):Hematology. 2nd Ed., McGraw-Hill, New York. 1977, pp. 453-544.

• 11) Valentine, W. N., Fink, K., Paglia, D. E., Harris, S. R. & Adams, W. S.:Hereditary hemolytic anemia with human erythrocyte pyrimidine 5:-nucleotidase deficiency. J. Clin. Invest., 54:866-879, 1974.
  pubmed

• 12) Valentine, W. N., Paglia, D. E., Tartaglia, A. P. & Gilsanz, F.:Hereditary hemolytic anemia with increased red cell adenosine deaminase (45-to70-fold) and decreased adenosine triphosphate. Science, 195:783-785, 1977.

• 13) Carson, P. E., Flanagan, C. L., Ickes, C. E. & Alving, A. S.:Enzymatic deficiency in primaquine-sensitive erythrocyte. Science, 124:484-485, 1956.
  pubmed

• 14) Valentine, W. N., Tanaka, K. R. & Miwa, S.:A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital nonspherocytic hemolytic anemia. Trans. Assoc. Amer. Physicians, 74:100-110, 1961.

• 15) Report of a WHO Scientific Group:Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. WHO Techn. Rep. Ser. 366, 1967.

• 16) Yoshida, A.:Amino acid substitution (histidine to tyrosine) in a glucose-6-phosphate dehydrogenase variant (G6PD Hektoen) associated with over-production. J. Mol. Biol.:52:483-490, 1970.

• 17) Beutler, E.:Red Cell Metabolism. A Manual of Biochemical Methods. 2nd Ed. Grune & Stratton, New York, 1975.

• 18) Beutler, E., Blume, K. G., Kaplan. J. C., Lohr, G. W., Ramot, B. & Valentine, W. N.:International Committee for Standardization in Haematology:Recommended methods for red-cell enzyme analysis. Brit. J. Haemat., 35:331-340, 1977.
  pubmed

• 19) 宮地隆興:ヘモグロビン異常. In 血液の病気, (今村幸雄ほか編), 中外医 学社. 1975, pp. 343〜363.

• 20) Bunn, H. F., Forget, B. G. & Ranney, H. M. (eds.):Hemoglobinopathies. W. B. Saunders, Philadelphia, 1977.

• 21) Pauling, L, Itano, H. A., Singer, S. J. & Wells, I. C.:Sickle cell anemia:A molecular disease. Science, 110:543-545, 1949.

• 22) 宮地隆興, 柴田進:異常血色素症 (サラセミアを含む) に関する調査. 厚生 省特定疾患溶血性貧血調査研究班 昭和51年度研究報告書 (班長三輪史朗), 1977, pp. 127〜134.

• 23) 三輪史朗, 松本昇:貧血とその治療. メディカルリサーチセンター. 1977.

P.259 掲載の参考文献

• 1) 野見山一生, 青木国雄, 加藤孝之, 三輪史朗, 前川正, 藤岡成徳:溶血性貧 血に関する疫学的研究 (1) 全国患者調査-溶血性貧血の疫学的特徴. 厚生省特 定疾患溶血性貧血調査研究班 昭和50年度研究報告書. p.p. 11. 1976.

• 2) 恒松徳五郎, 他:後天性溶血性貧血-自己免疫性溶血性貧血症 (AIHD) を 中心として:内科, 31:643, 1973.

• 3) 恒松徳五郎, 他:後天性溶血性貧血-治療に必要な自己免疫性溶血性貧血症 の統計的数値. 本邦統計集, 日本臨床, 昭和49年7月, p. 1778.

• 4) Lo Buglio, A. F., Cotran, R. S. and Jandl, J. H.:Red cells coated with immunoglobulin G;Binding and sphering by mononuclear cells in man. Science, 158:1582, 1967.
  pubmed

• 5) Engelfriet, C. P., Borne, AE. G. KR. V. D., Becker, D. and Van Loghem, JJ.:Autoimmune haemolytic anemia;serological and immunochemical characteristics of the autoantibodies;mechanisms of cell destruction. Ser. Haemat., 7:328, 1974.

• 6) Dacie, J. V.,:Autoimmune hemolytic anemia. Arch. Intern. Med., 135:1293, 1975.
  pubmed

• 7) Rosenau, W.:Target cell destruction. Fed. Proc., 27:34, 1968.
  pubmed

• 8) Henney, C. S.:Studies on the mechanism of lymphocyte mediated cytolysis. II. The use of various target cell markers to study cytolytic events. J. Immunol., 110:73, 1973.
  pubmed

• 9) Martz, E., Burakoff, SJ. and Benacerraf, B,:Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement. Proc. Nat. Acad. Sci. USA, 71:177, 1974.
  pubmed

• 10) Ferluga, J. and Allison, A. C.:Observations on the mechanism by which T-lymphocytes exert cytotoxic effects. Nature, 250:673, 1974.
  pubmed

• 11) Henkart, P. and Blumenthal, R.:Interaction of lymphocytes with lipid bilayer membranes;a model for lymphocyte-mediated lysis of target cells. Proc. Nat. Acad. Sci. USA, 72:2789, 1975.

• 12) Danon, D.:A rapid micromethod for recording red cell osmotic fragility by continuous decrease of salt concentration, J. Clin. Path., 16:377. 1963.

• 13) Ito, Y., Weinstein, M. A., Aoki, I., Harada, R. and Kimura, E.:The coil planet centrifuge. Nature, 212:985, 1966.

• 14) 神奈木玲児, 恒松徳五郎:自己免疫性溶血性貧血 (温式) における赤血球膜抵抗の研究. 厚生省特定疾患溶血性貧血調査研究班, 昭和51年度研究報告書, p. 225, 1977.

• 15) Dacie, J. V.:The haemolytic anaemias, congenital and acquired. II. The autoimmune haemolytic anaemias. P. Churchill Ltd., London, 1962.

• 16) Bielschowsky, M., Helyer, BJ. and Howie, J. B.:Spontaneous haemolytic anaemia in mice of the NZB/B1 strain. Proc. Univ. Otago Med. School, 37:9, 1959.

• 17) Dauphinee, MJ. and Talal. N.:Alteration in DNA synthetic response of thymocytes from NZB nice of different ages, Proc. Nat. Acad. Sci. USA, 70:3769, 1973.

• 18) Hardin, J. A., Chused, T. M. and Steinberg, A. D.:Suppressor Cells in the graft vs host reaction.:J. Immunol, 111:650, 1974.

• 19) Barthold, D, R., Kysela, S. and Steinberg, A. D.:Decline in suppressor T cell function with age in female NZB mice. J. Immunol 112:9, 1974.
  pubmed

• 20) Cantor, H. and Boyse, E. A.:Functional subclasses of T-lymphocytes bearing different Ly antigens. J. Exp. Med. 141:1376, 1975.
  pubmed

• 21) Cantor, H., McVay-Budreau, J., Hugenberger, J., Naidorf, K., Shen, F. W., and Gershon, R. K.:Immunoregulatory circuits among T-cell sets. II. Physiologic Role of feedback inhibition in vivo:Absence in NZB mice. J. Exp. Med. 147:1116, 1978.

• 22) Bach, J. F., Dardenne, M. and Salomon, J, C.:Absence of serum thymosin-like activity in adult NZB and (NZBxNZW) F1 mice. Clin. Exp. Immunol. 14:247, 1973.

• 23) Gershwin, M. E., Ikeda, R. M., Kruse, W. L, Wilson, F., Shifrine, M. and Spangler, W.:Age dependent loss in New Zealand Mice of morphological and functional characteristics of thymic epithelial cells. J. Immunol. 120:971, 1978.
  pubmed

• 24) 池原進, 川路尚徳, 笠原勝幸, 神奈木玲児, 坂口志文, 浜島義博, 増田徹: 自己免疫疾 患発症に 及ぼす 胸腺因子の効果, 日本免疫学会総会記録, 7: 109, 1977.

• 25) Goldstein, A. L, Guha, A., Zatz, M. M., Hardy, M. A. and Whote., A.:Purification and biological activity of thymosin, a hormon of the thymus gland. Proc. Nat. Acad. Sci. USA, 69:1800, 1972.

• 26) Goldstein, A. L., Low, T. L. K., McAdoo, M., McClure, J., Thurman, G. Rossio, T., Lai, C. Y., Chang, D., Wang, S. S., Harvey, C., Ramal, A. H. and Meienhofer, J.:Thymosin al;isolation and sequence analysis ofan immunologically active thymic polypeptide. Proc. Nat. Acad. Sci. USA. 74:725, 1977.

• 27) Talal, N., Dauphinee, M. J. Pillarisetty, R. and Goldblum, R.:Effect of thymosin on thymocyte proliferation and autoimmunity in NZB mice. Ann. NY. Acad. Sci. 249:438, 1975.

• 28) Ikehara, S., and Kannagi, R. unpublished results.

• 29) Ikehara, S., Kawaji, N., Kasahara, M., Kannagi, R., Sakaguchi, S., Hamashima, Y. and Masuda, T.:Spontaneous Autoimmune Disease in Rhino Mice, III. Effect of a Thymus Factor on the Development of Autoimmune Disease in Rhino Mice. Submitted.

• 30) Terasaki, P. I., Mottironi, V. D. and Bareett, E. V.:Cytotoxins in Disease. Autocytotoxins in Lupus. N. Eng. J. Med. 283:724, 1970.

• 31) Shirai, T. and Mellors, R. C. ;Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc. Nat. Acad. Sci. USA. 68:1412, 1971.
  pubmed

• 32) Helperin, I. C., Minogue, W. F. and Kumninos, Z. D.:Autoimmune hemolytic anemia and myasthenia gravis associated with thymoma. New. Engl J. Med. 275:663. 1966.

• 33) Wilmers, MJ. and Russell, P. A.:Autoimmune haemolytic anaemia in an infant treated by thymectomy. Lancet, ii:915, 1963.

• 34) Karaklis, A. et al.:Thymectomy in an infant with autoimmune haemolytic anaemia. Lancet, ii:778-780,1964.

• 35) Pirofsky, B.:Autoimmunization and autoimmune hemolytic anemias. Williams and Wilkins, Baltimore, 1969.

• 36) Da Costa, J. A. G., White, A. G., Parker, A. C. and Grigor, G. B.:Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells.:J. Clin. Path., 27:353, 1974.
  pubmed

• 37) Dameshek, W.:ACTH in leukemia-discussion. Blood, 5:791, 1950.

• 38) Gardner, F.:ACTH in leukemia-discussion. Blood, 5. 791, 1950, 3:24, 1972.

• 39) Allgood, J. W. and Chaplin, H.:Idiopathic acquired autoimmune hemolytic anemia.:A review of forty-seven cases treated from 1955 through 1965. Am. J. Med., 43:254, 1967.
  pubmed

• 40) Murphy, S. and Lobuglio, A. F.:Drug therapy of autoimmune hemolytic anemia. Sem. Hematol., 13:323, 1976.

• 41) Rosse, W. F.:Quantitative immunology of hemolytic anemia. II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J. Clin. Invest., 50:734, 1971.
  pubmed

• 42) Worlledge, SM.:Immune drug-induced hemolytic anemias;Seminars in Hematology 10;327, 1973.
  pubmed

• 43) 三輪史朗, 恒松徳五郎:薬剤誘発性溶血性貧血の共同調査報告, 厚生省特定疾患溶血調査研究班, 昭和51年度研究報告書, 321, 昭和52年.

• 44) Dacie, J. V. et al., Paroxysmal nocturnal haemoglobinuria:Clinical manifestations, haematology and nature of the disease. Ser. Haematol., V. 3,:3. 1972.

• 45) Lewis, S. M. et al. The a plastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome. Brit. J. Haematol., 13:236, 1967.

• 46) Jenkins, D. E.:Diagnostic tests for paroxysmal nocturnal haemoglobinuria. Ser. Haematol V. 3:24,1972.

• 47) Hintz Jr, C. F.:Acid Hemolysis Revisited. Sem. Haemat., 13:201, 1976.

• 48) Canellos, G. P. et al.:Effects of sulfhydryl inhibition on the erythrocyte in paroxysmal nocturnal hemoglobinuria. Brit. J. Haematol., 18:269, 1970.

• 49) Mengel, C. E. et al.:Biochemistry of PNH cells. Ser. Haemat., V. 3:88, 1972.

• 50) Mengel, CE. et al.:Studies of paroxysmal nocturnal hemoglobinuria erythrocytes:Increased lysis and lipid peroxide formation by hydrogen peroxide, J. Clin. Invest., 46:1715, 1967.
  pubmed

• 51) Sirchia, G. et al.:Leucocyte antigen-antibody reaction and lysis of paroxysmal noctunal hemoglobinuria erythrocytes. Blood 36:334, 1970.

• 52) Hartmann, RC. et al. Viewpoints on the management of paroxysmal nocturnal hemoglobinuria (PNH) . Ser Haematol. v. 3:42, 1972.

• 53) Mengel, C. E. et al.:Increased hemolysis after intramuscular iron administration in patients with paroxysmal nocturnal hemoglobinuria:Report of four occurrences in six patients, and speculation on a possible mechanism. Blood, 26:74, 1965.
  pubmed

• 54) Rosse, W. F. et al.:The effect of iron therapy in paroxysmal nocturnal hemoglobinuria. Blood, 36:559, 1970.
  pubmed

• 55) Firkin, F. et al:Glucocorticoid management of paroxysmal nocturnal hemoglobinuria. Aust. Ann. Med., 17:127, 1968.
  pubmed

• 56) Gardner, F. H. et al.:The use of clinical dextran in patients with paroxysmal nocturnal hemoglobinuria. J. Lab. Clin. Med. 55:946, 1960.
  pubmed

P.276 掲載の参考文献

• 1) Jacobson, L. O., Goldwasser, E., Fried, W. and Plzak, L:Role of the kidney in erythropoiesis. Nature, 179:633, 1957.
  pubmed

• 2) Erslev, A. J.:The search for erythropoietin. New Engl. J. Med., 284:849, 1971.
  pubmed

• 3) Gordon, A. S., Cooper, G. W. and Zanjani, E. D.:The kidney and erythropoiesis. Semin, Hematol. 4:337, 1967.
  pubmed

• 4) Fisher, W. J. et al.:Erythropoietin inhibitor in kidney extracts and plasma from anemic uremic human subjects. Blood 31:440, 1968.

• 5) Erslev, A. J.:In vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood 44:77, 1974.
  pubmed

• 6) Peschle, C. et al.:Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan. Blood, 47:325, 1976.
  pubmed

• 7) 森山美昭:腎性貧血, 血液疾患最近の進歩くあすへの内科展望>, 高久史麿 編, 金原出版, p. 40, 1978.

• 8) Erslev, A. J.:Erythropoietic function of the kidney, in Physiology of the Human Kidney, edited by L. G. Wesson, p. 521. Grune&Stratton, New York, 1969.

• 9) 高久史磨:腎不全とエリトロポエチン, 日本臨床32:528, 1974.

• 10) Abbrecht, P. H. and Greene, J. A.:Serum erythropoietin after renal homotransplantation. Ann. Intern. Med. 65:908, 1966.
  pubmed

• 11) Dzurich, R., et a1.:The isolation of an inhibitor of glucose utilization from the serum of uremic subjects. Clin. Chim. Acta，46:77,1973.

• 12) Lange, K., et al.:Transketolase inhibition as a mechanism in uremic neuropathy. Uremia, ed. Kluthe, R., Berlyne, G. & Burton, B., Thieme, Stuttgart, p. 25, 1972.

• 13) Brain, M. C. et al.:Microangiopathic hemalytic anemia in the possible role of vascular lesions in pathogenesis. Brit. J. Haemat, 8:358, 1962.

• 14) Gianantonio, C. et al.:The hemolytic-uremic syndrome. J. Pediatr. 64:478, 1964.
  pubmed

• 15) Freedman, M. H. and Saunders, E. F.:Erythroid stem cell studies in chronic renal failure, 16th Intern Cong. Hemat. Kyoto, Japan, 1976.

• 16) Stewart, J. H., and Castaldi, P. A.:Uremic bleeding:A reversible platelet defect corrected by dialysis. Quart. J. Med. 36:409, 1967.
  pubmed

• 17) Richet, G. et al.:Acute erythroblastopenia due to anuria, Presse. Med. 62:50, 1954.
  pubmed

• 18) VanDyke, D. C. et al.:Erythropoietin therapy in the renoprival patient. Semiannual Report on Biology & Medicine, Donner Lad., Lawrence Radiation Lab., Barkeley, California, p. 127, 1967.

• 19) Gordon, A. S. et al.:Androgen actions on erythropoiesis. Ann. N. Y. Acad. Sci. 149:318, 1968.
  pubmed

• 20) Fried, W. et al.:The erythropoietic Stimulating effects of androgens. Ann. N. Y. Acad. Sci. 149:356, 1968.
  pubmed

• 21) Edwards, M. S., Curtis, J. R.:Use of cobaltous chloride in anemia of maintenance-hemodialysis patients. Lancet II:582, 1971.

• 22) Nashan, D. G. et al.:Hematopoiesis in renal failure. Kidney Hormones, ed. by Fisher, J. W. Academic Press, New York, p. 411, 1971.

• 23) Naets, J. P., Wittek, M.:Erythropoiesis in anephric Man. Lancet I:941, 1968.
  pubmed

• 24) Allan. J. Erslev:Anemia of endocrine disorders. Hematollogy (Williams, Second Edition):p. 295.

• 25) 白倉卓夫:内分泌疾患と貧血. 「血液疾患最近の進歩」(高久史麿編):p. 160.

• 26) D. W. Golge:Thyroid hormones stimulate erythropoiesis in vitro. Brit. J. Haemat., 37:173, 1977.

• 27) Luis A Malgor:Direct effect of thyroid hormones on bone marrow erythroid cells of rats. Blood, 45:671, 1975.

• 28) Tudhope:Anaemia in hypothyroidism. Incidence, pathogenesis, and response to treatment. Quart. J. Med., 29:513-537, 1960.
  pubmed

• 29) 前川正:内分泌疾患の貧血. 「新内科学大系 (49)」, 血液造血器疾患I:p. 344.

• 30) Golde, D. W.:Potentiation of erythropoiesis in vitro by dexamethasone. J. Clin. Invest., 57:57, 1976.
  pubmed

• 31) Singer, J. W., et al.:Steroids and Hematopoiesis I. The effect of steroids on in vitro erythroid colony growth;structure/activity relationships. J. Cell. Physiol., 88:127, 1976.
  pubmed

• 32) Irving, R. A., et al.:The regulation of haemoglobin synthesis in cultured chick blast derms by steroids related to 5B-androstane. Bioch. J, 154:81, 1976.

• 33) Shahidi, N. T., et al:Androgens and erythropoiesis, New Engl. J. Med., 289:72, 1973.
  pubmed

• 34) Stevenson, A. F. G.:Sex difference and the influence of endotoxin and hypertransfusion in spleen colony formation. Blut, 32:361, 1976.

• 35) Michael Boxer:Anemia in Primary Hyperparathyroidism, Arch. Intern. Med., 137:588, 1977.

P.283 掲載の参考文献

• 1) 和田武雄:悪液質, 中外医学双書, 1968.

• 2) Crowther, D. & Bateman, C. J. T.:Hematological aspects of systemic disease. Malignant disease. 1:447, 1972.

• 3) 漆崎一朗:悪性腫瘍と貧血, 内科, 31:608, 1973.

• 4) 漆崎一朗:悪性腫瘍における貧血, 貧血のすべて, 14:285, 1974.

• 5) Brain, M. C., Azzopardi J. G., Baber, L. R. I., Pinco, G. F., Roberts, P. D. & Dacie, J. V.:Microangiopathic haemolytic anaemia and mucin forming adenocarcinoma. Brit. J. Haemat., 18:183, 1970.

• 6) Nakahara, W., Fukuoka, F.:The newer concept of cancer toxin. Advances Cancer Res. 51:157, 1958.

• 7) 漆崎一朗:癌と貧血, 臨床血液, 14:425, 1973.

• 8) Firat, O. & Banzon, J.:Erythropoietic effect of plasma from patients with advanced cancer. Cancer, 31:1355, 1971.

• 9) Zukcer, S., Friedman, S. & Lysik, R. M.:Bone marrow erythropoiesis in the anemia of infection, inflammation and malignancy. J. Clin. Invest., 53:1132, 1974.

P.290 掲載の参考文献

• 1) Wintrobe, M. M.:A plastic anemia. Clinical hematology, Lea and Febigar, Philadelphia, p. 1744, 1974.

• 2) 高久史麿, 青木国雄, 清水弘之:二次性再生不良性貧血の臨床疫学的検討- 特に薬剤との関連について-:再生不良性貧血IV (再不貧班昭和50年業績集) p. 45, 1976.

• 3) 高久史麿, 武藤良知:Chloramphenicol と再生不良性貧血に関する疫学的 ならびに臨床血液学的検討:再生不良性貧血V (再不貧班昭和51年業績集) p. 79, 1977.

• 4) Ratzan, RJ., Moore, M. A. S., and Yunis, A. A.:Effect of chloramphenicol on the in vitro colony forming cell. Blood 43:363, 1974.

• 5) Hiroshi Hara, Masatoshi Kohsaki, Kohji Noguchi and Kiyoyasu Nagai:Effect of Chloramphenicol on in Vitro Colony Formation from Erythrocytic Precursors. Amer. J. Haemat. (in press)

P.298 掲載の参考文献

• 1) 平嶋邦猛:赤血球系における障害の回復. 「放射線障害の回復」 江上信夫 編, p. 120, 朝倉書店, 1970.

• 2) 中尾喜久:原子爆弾被爆者及びX線照射動物の骨髄像の変化に就いて. 血液 討議会報告, 第5輯:361〜374. 永井書店, 大阪, 1953.

• 3) 市丸道人, 石丸寅之助:原爆放射線被曝と再生不良性貧血. 広島, 長崎の原爆被爆者の再生不良性貧血の発生率, 1950〜1973年, 再生不良性貧血IV (厚生省再不貧班昭50業績集):139〜145, 1975.

• 4) Lewis, E. B.:Leukemia, multiple myeloma, and aplastic anemia in American radiologists. Science, 142:1492-1494, 1963.
  pubmed

• 5) 北畠隆, 渡辺強, 斉藤明, 中村実:本邦放射線技師 における再生不良性貧血, 再生不良性貧血IV (厚生省再不貧班 昭50業績集):157〜160, 1975 (日本医放会誌36:225〜228, 1976)

• 6) Spiers, J., Cluff, L. E. and Urry, W.:A plastic anemia following administration of thorotrast J. Lab. Clin. Med. 32:147-154, 1947.

• 7) 森武三郎:トロトラスト晩発障碍の疫学的および病理学的研究. 放射線科学 20:91〜96, 1977.

• 8) 島峰徹郎, 森武三郎:トロトラストによる骨髄病変. 再生不良性貧血V (厚 生省再不貧班昭51業績集):123〜129, 昭51年.

• 9) Court Brown, W. M. and Doll, R.:Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis Brit. Med. J. 2:1327-1332, 1965.

• 10) 北畠隆, 斉藤明, 酒井邦夫, 稲越英機, 渡辺強, 日向浩:放射線治療による 再生不良性貧血誘発の可能性に関する疫学的推論. 再生不良性貧血V (厚生 省再不貧班昭51業績集):131〜135, 昭51年.

• 11) 青木國雄, 大谷元彦:再生不良性貧血患者の全国調査, 第2報. 再生不良性 貧血II (厚生省再不貧班昭48業績集):1〜8, 1974.

• 12) 北畠隆, 斉藤明, 日向浩:放射線被曝と再生不良性貧血発症との関連性につ いて. 再生不良性貧血IV (厚生省再不貧班昭50業績集):151〜155, 昭50年.

• 13) 粟冠正利:乳癌の放射線治療後の白血病頻度. 日本医放会誌, 24:466〜467, 1974.

• 14) 山崎岐男, 黒川茂樹, 北畠隆:乳癌照射と 白血病の誘発. 日本医放会誌, 29:44〜48, 1969.

• 15) Lange, R. D., Wright, S. W., Tomonaga, M., Kurasaki, H., Matsuoka, S. and Matsunaga, H.:Refractory anemia occurring in survivors of the atomic bombing in Nagasaki, Japan. Blood 10:312-324, 1955.

• 16) 市丸道人:原爆放射線による造血臓器障害. 臨床血液, 14:1255〜1263, 1973.

3. 各科における貧血

P.312 掲載の参考文献

• 1) 浅野清治:小児貧血, 金原出版, 1959.

• 2) 小児内科特集, 小児の貧血, 小児内科9巻8号, 1977.

• 3) 中山健太郎:小児期貧血の定義と分類. 小児内科, 9 (8):1177〜1180, 1977.

• 4) 中山健太郎, 中川俊郎:小児血液疾患の実態調査成績, 小児科臨床, 27: 1041〜1047, 1974.

• 5) 中山健太郎:健康小児の軽度貧血と鉄欠乏, クリニカ, 2 (1):241〜245, 1975.

• 6) Nakayama, K., and Nakagawa, T.:Prevalence and clinical states of aplastic anemia among children in Japan, in "A plastic Anemia"edited by Hibino, S. et al, Tokyo University Press, 1978.

• 7) 中山健太郎, 他:乳幼児の再生不良性貧血の分類と成因に関する調査成績, 昭和50年度再生不良性貧血研究班報告書, p. 267〜275.

• 8) 日比野進・編:再生不良性貧血, 医学書院 (印刷中)

P.331 掲載の参考文献

• 1) Council on Foods and Nutrition, Committee on Iron Deficiency:Iron deficiency in the United States. JAMA 203:407-412, 1968.

• 2) Nutritional Anemias, Report of a WHO Scientific Group, WHO Technical Report Series. No. 405, 1968.
  pubmed

• 3) Taguchi, H. et al,:Folic acid status in pregnancy in Japanese women. Acta Haemat. Jap. 34:128-136, 1971.
  pubmed

• 4) 安木邦昌:妊娠, 分娩, 産褥時の末梢血及び骨髄の血液像の変化について, 日産婦会誌, 16:417〜426, 1964.

• 5) 古谷博:妊婦の貧血に関する研究. 日産婦誌, 17:683〜692, 1965.

• 6) 本郷基弘, 他:妊娠貧血の研究 (1) . 臨床婦人科産科, 17:291〜297, 1963.

• 7) 本郷基弘:妊娠貧血における sideroblast に関する研究-骨髄細胞浮遊回転 培養法を応用して-. 日産婦会誌, 15:296〜304, 1963.

• 8) 本郷基弘:妊娠貧血に関する研究 (末梢血の検索を中心として). 日産婦会誌, 15:27〜36, 1963.

• 9) Layrisse, M. et al.:Food iron absorption:A comparison of vegetable and animal foods. Blood. 33:430-443, 1969.
  pubmed

• 10) Reqirement of Ascorbic Acid, Vitamin D, vitamin B 12, Folate and Iron. Report of Joint FAO/WHO Expert Group. WHO Technical Report Series. No. 452, 1970.

• 11) 古谷博, 他:妊婦の貧血とその治療. 産婦人科治療, 29:25〜31, 1974.

• 12) 岡崎通, 島地泰敏:妊娠と鉄欠乏-妊娠における血清 transferrin の意義- 産婦人科の実際, 25:635〜646, 1975.

• 13) Walters, G. O. et al.:Serum ferritin concentration and iron stores in normal subjects. J. Clin. Path. 26:770-772, 1973.
  pubmed

• 14) 漆崎一朗:血液学における Ferritin の意義. 目血会誌, 39:571〜583, 1976.

• 15) Herbert, V.:Minimum daily adult folate reqirement. Arch. Intern. Med. 110:649-652, 1962.

• 16) Willoughby, M. L. N.:An investigation of folic acid requirements in pregnancy. II. Brit. J. Haemat. 13:503-509, 1967.

• 17) Metz, J,:Folate deficiency conditioned by lactation. Amer. J. Clin. Nutr. 23:843-847, 1970.
  pubmed

• 18) 田口博国, 他:食品中の葉酸含量に関する研究 (I) 各種食品の葉酸含量, ビタミン, 46:313〜318, 1972.
  Medical*Online

• 19) 三輪史朗, 他:溶血性貧血に関する全国疫学調査, 日本医事新報, No. 2746: 24〜31, 1976.

• 20) 恒松徳五郎:自己免疫性溶血性貧血の臨床, 日内会誌, 64:451〜460, 1975.

• 21) 星崎東明, 他:自己免疫性溶血性貧血と妊娠, 分娩. 臨床免疫, 4:705〜711, ] 972.

• 22) Chaplin, H. et al.:Pregnancy and idiopathic autoimmune hemolytic anemia:A prospective study during 6 months gestation and 3 months postpartum. Brit. J. Haemat. 24:219-229, 1973.
  pubmed

• 23) 岩崎一郎:再生不良性貧血の臨床, 日内会誌, 64:401〜410, 1975.

• 24) 星崎東明, 他:血液疾患と妊娠分娩, 日赤医学, 27:95〜104, 1975.

• 25) 中山志郎, 他:妊娠, 分娩と再生不良性貧血. 臨床血液, 14:659〜667, 1973.

• 26) Jepson, J. H. and Lowenstein, L.:The effect of teststerone, adrenal steroids and prolactin on erythropoiesis. Acta Haemat. 38:292-299, 1967.

• 27) 寺尾俊彦:血液疾患と妊娠分娩. 産婦人科治療, 32:305〜317, 1976.

• 28) 半田誠, 他:分娩後, 完全寛解導入に成功した急性白血病の1例. 臨床血液, 19:351〜355, 1978.

• 29) 小宮正文, 他:特発性血小板減少性紫斑病の全国疫学調査. 日本医事新報, No. 2738:27〜34, 1976.

• 30) 赤須文男:妊娠時の薬物療法. 現代産婦人科大系. 小林隆ほか監修, 第13巻 E, 薬物療法総論, P. 61〜72, 中山書店, 東京, 1972.

P.346 掲載の参考文献

• 1) Ehtisham, M., and Cape, R. D. T. ;Protocol for diagnosing and treating anemia. Geriatrics, 32:91, 1977.

• 2) 前川正, 衣笠恵士:老年期の正常血液像. 日血会誌, 20 (Suppl):105, 1957.

• 3) 前川正, 衣笠恵士:老人血液像. 日血全書1:160, 1963.

• 4) Hawkins, W. W., Speck, E., and Leonard, V. G.:Variation of the hemoglobin level with age and sex. Blood, 9:999, 1954.
  pubmed

• 5) 白倉卓夫, 村井善郎, 武田敏雄, 森徳雄:老年者末梢血液像と赤血球産生能 の変化. 日老医誌15:151, 1978.

• 6) 亀山正邦:部位別にみた脳梗塞の成因. 日本臨牀, 35:206, 1977.

• 7) 目比野進, 瀧田資也:老年者と血液. Geriatric Medicine 10:55, 1972.

• 8) Danis, M. L, Upton, A. C., and Satterfield, L. C.:Growth and senescence of the bone marrow stem cell pool in RFM/Un mice. Proc. Soc. Exp Biol Med., 137:1452, 1971

• 9) Trentin, J. J.:Influence of hematopoietic organ stroma (Hematopoietic inductive microenvironments) on stem cell differentiation in regulation of hematopoiesis. Vol. 1, edited by Gordon, A. S. p 159. Appelton-Century-Crofts, New York, 1970

• 10) 白倉卓夫, 田中英雄, 武田敏雄, 村井善郎:老年者のHemoglobin濃度と血中Erythropoietin 活性値. 医学のあゆみ 93:316, 1975

• 11) 白倉卓夫, 村井善郎, 武田敏雄:老年造血幹細胞プールの変化, 96:507, 1976

• 12) Takaku, F.:Studies on the anemia in the aged with special reference to the production and destruction of erythrocytes. Acta Haemat. Jap. 22:464, 1959

• 13) 平木潔:老年者の骨髄造血機能の特長について. 日老医誌, 8:47, 1971

• 14) 平木潔, 長尾忠美:老年者における血液疾患の特徴. Geriatric Med. 10: 7, 1972

• 15) MacKinney, A. A.:Effect of aging on the peripheral blood lymphocyte count. J. Geront., 33:213, 1978
  pubmed

• 16) Denes, S:Morphologic changes in the leucocytes with aging. J. Amer. Geriat. Soc. 12:571, 1964

• 17) Dougherty, J. H., and Rosenblatt, L S.,:Changes in the hemogram of the beagle with age. J. Geront. 20:131, 1965

• 18) 滝川清治, 平岩甫, 米本剛:老年者の血液所見について. 臨床の日本, 2: 385, 1960

• 19) Elwood, P. C., Shinton, N. K., Wilson, C. I. D., Sweetman, P., and Frazer, A. D.:Hemoglobin, vitamin B 12 and folate levels in the elderly. Brit. J. Haemat. 21;557, 1971

• 20) Hughes, D., Elwood, P. C., Shinton, N, K., and Wrighton, R. J.:Clinical trial of the effect of vitamin B 12 in elderly subjects with low serum B 12 levels. Brit. Med. J. 2:458, 1970

• 21) Bertolini, A. M:Modifications of cellulal enzymatic systems during ageing. Gerontologia, 6:175, 1962

• 22) 海老原隆郎:老年者貧血に関する研究. 東京医科大学雑誌32:1065, 1974

• 23) 野手信哉:老年者貧血とホルモン. 日老会誌, 1:182, 1964

• 24) Parsons, P. L., Withey, J. L., and Kilpatrick, G. S.:The prevalence of anaemia in the elderly. Practioner 195:656, 1965

• 25) Burnett, N T.:Common causes of anaemia in the elderly, J. Amer Geriat. Soc. 14:358, 1966
  pubmed

• 26) Mahmud, K., Ripley, D., Swaim, W. R. and Doscherholmen, A.:Hematologic complications of partial gastrectomy. Ann. Surg. 177:432, 1973
  pubmed

• 27) Inada, M., and Glass, G. B. J.:Effect of prolonged administration of homologous and heterologous intrinsic factor antibodies on the parietal and peptic cell masses and the secretory function of the rat gastric mucosa. Gastroenterology, 69:396, 1975

• 28) 前川正, 衣笠恵士, 高久史磨:老年病学, 第4章, 血液疾患. 村上元孝, 亀山正邦編, 南江堂, p332, 1976

• 29) 脇坂行一:わが国における 白血病の 地理病理学的観察. 内科17巻 No. 2, 225, 1966

• 30) 与那原良夫, 伊藤宗元, 栗林宣雄:高令者における白血病. 診断と治療, 56:505, 1968

• 31) Rheingold, J. J., Kaufman, R. Adelson, E &Lear, A.:Smoldering acute leukemia, New Engl. J. Med. 268:812, 1963
  pubmed